Allogene Therapeutics (ALLO) Shares Outstanding (2018 - 2026)
Allogene Therapeutics (ALLO) Shares Outstanding (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - | 240.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.29 Mn |
| Dec 31, 2025 | 220.62 Mn |
| Sep 30, 2025 | 222.04 Mn |
| Jun 30, 2025 | 218.93 Mn |
| Mar 31, 2025 | 215.36 Mn |
| Dec 31, 2024 | 194.81 Mn |
| Sep 30, 2024 | 209.19 Mn |
| Jun 30, 2024 | 190.03 Mn |
| Mar 31, 2024 | 169.13 Mn |
| Dec 31, 2023 | 156.93 Mn |
| Sep 30, 2023 | 167.65 Mn |
| Jun 30, 2023 | 146.80 Mn |
| Mar 31, 2023 | 144.56 Mn |
| Dec 31, 2022 | 143.15 Mn |
| Sep 30, 2022 | 143.66 Mn |
| Jun 30, 2022 | 143.39 Mn |
| Mar 31, 2022 | 141.36 Mn |
| Dec 31, 2021 | 135.82 Mn |
| Sep 30, 2021 | 137.03 Mn |
| Jun 30, 2021 | 134.83 Mn |